Mediphar Labs. has launched in the Lebanese market, OMEPRAL 20 mg powder for oral suspension in sachets.

OMEPRAL® is used in conditions where inhibition of gastric acid secretion may be beneficial.

We are proud to be introducing this medicament into the market, providing patients with a new and effective treatment option.
OMEPRAL® powder for oral suspension is reimbursed by local National Social Security Fund (NSSF).
OMEPRAL® powder for oral suspension is available in the below dosage:
Omeprazole 20 mg, pack of 12 sachets.

Back to All News
We care about your questions and concerns. Please call the consumer healthcare service:
+961 4 540056 or by email: